MIL-OSI: Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.
EQS-News: TVM Life Science Management GmbH / Key word(s): Miscellaneous Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis 20.07.2023 / 14:00 CET/CEST The issuer is solely responsible for the conten.
PSP Swiss Property AG / Key word: Quarter Results
In a challenging market environment, PSP Swiss Property once again achieved a solid operating result in Q1 2023. Ebitda and vacancy guidance for. | May 5, 2023